OKUTUCU, M. Et Al. 2021. Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?. BMC OPHTHALMOLOGY , vol.21, no.1 .

OKUTUCU, M., FINDIK, H., ASLAN, M. G., & ARPA, M., (2021). Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?. BMC OPHTHALMOLOGY , vol.21, no.1.

OKUTUCU, MURAT Et Al. "Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?," BMC OPHTHALMOLOGY , vol.21, no.1, 2021

OKUTUCU, MURAT Et Al. "Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?." BMC OPHTHALMOLOGY , vol.21, no.1, 2021

OKUTUCU, M. Et Al. (2021) . "Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?." BMC OPHTHALMOLOGY , vol.21, no.1.

@article{article, author={MURAT OKUTUCU Et Al. }, title={Increased serum concentration of netrin-1 after intravitreal bevacizumab injection: is it a compensatory mechanism to counteract drug side effects?}, journal={BMC OPHTHALMOLOGY}, year=2021}